Home Newsfeeds Credit Suisse Downgrades Banco De Chile to Neutral

Credit Suisse Downgrades Banco De Chile to Neutral

Credit Suisse analyst Alonso Garcia downgrades Banco De Chile (NYSE:BCH) from Outperform to Neutral.

byBenzinga Newsdesk

August 19, 2022

1 minute read

Credit Suisse analyst Alonso Garcia downgrades Banco De Chile (NYSE:BCH) from Outperform to Neutral.

Analyst Initiates Coverage On Accolade, Says ‘Differentiated In Growing Market’

By Vandana Singh

February 2, 1:51 PM

Raymond James initiated coverage on Accolade Inc (NASDAQ:ACCD) with an Outperform rating and a $15 price target. Employers have increasingly added disconnected…

ACCD

ZK International Group Co., Ltd., Wins $8M Bid With Chongqing Gas Group To Supply The Municipal Gas Infrastructure Project, Thus Strengthening Its Competitive Edge In The Western China Gas Market

By Benzinga Newsdesk

December 19, 9:10 AM

ZK International Group Co., Ltd. (NASDAQ:ZKIN) ("ZKIN", "ZK International" or the "Company"), a leading designer, engineer, manufacturer, and supplier of patented high-performance stainless steel and

ZKIN

Roche, Pfizer Race To Find Next Ozempic As Pharma Giants Hustle To Join Obesity Treatment Market

By Neil Dennis

December 4, 5:20 PM

Weight-loss drugs such as Ozempic and Mounjaro are the leading blockbusters for a new epidemic

ALT

Movers
News

What’s Going On With CXApp Stock Wednesday?

By Adam Eckert

April 3, 8:55 AM

CXApp shares rallied more than 150% to start the week after the company announced a partnership with Alphabet Inc's Google Cloud. The stock pulled back significantly on Tuesday, closing the day down 27.1% at $4.48, but it's moving higher again on Wednesday.

CXAI

Credit Suisse Downgrades Banco De Chile to Neutral

Related Posts

Analyst Initiates Coverage On Accolade, Says ‘Differentiated In Growing Market’

ZK International Group Co., Ltd., Wins $8M Bid With Chongqing Gas Group To Supply The Municipal Gas Infrastructure Project, Thus Strengthening Its Competitive Edge In The Western China Gas Market

Roche, Pfizer Race To Find Next Ozempic As Pharma Giants Hustle To Join Obesity Treatment Market

What’s Going On With CXApp Stock Wednesday?